Page last updated: 2024-08-22

chromium and concanamycin a

chromium has been researched along with concanamycin a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, T; Froelich, CJ; Fujita, S; Kuzushima, K; Otsuki, T; Yasukawa, M	1

Other Studies

1 other study(ies) available for chromium and concanamycin a

Article	Year
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-01, Volume: 10, Issue:21 Topics: Antigens, Neoplasm; Bone Marrow Cells; Calcium; Cell Line; Cell Line, Tumor; Chromium; Cytoplasmic Granules; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Exocytosis; Flow Cytometry; Genes, MHC Class I; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Macrolides; Membrane Glycoproteins; Multiple Myeloma; Peptides; Perforin; Pore Forming Cytotoxic Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Cytotoxic; Treatment Outcome; WT1 Proteins	2004

Article

Year

Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-01, Volume: 10, Issue:21

Topics: Antigens, Neoplasm; Bone Marrow Cells; Calcium; Cell Line; Cell Line, Tumor; Chromium; Cytoplasmic Granules; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Exocytosis; Flow Cytometry; Genes, MHC Class I; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Macrolides; Membrane Glycoproteins; Multiple Myeloma; Peptides; Perforin; Pore Forming Cytotoxic Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Cytotoxic; Treatment Outcome; WT1 Proteins

2004